These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 26420190)

  • 21. The impact of body mass index on complication and survival in resected oesophageal cancer: a clinical-based cohort and meta-analysis.
    Zhang SS; Yang H; Luo KJ; Huang QY; Chen JY; Yang F; Cai XL; Xie X; Liu QW; Bella AE; Hu RG; Wen J; Hu Y; Fu JH
    Br J Cancer; 2013 Nov; 109(11):2894-903. PubMed ID: 24201750
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A high body mass index in esophageal cancer patients does not influence postoperative outcome or long-term survival.
    Blom RL; Lagarde SM; Klinkenbijl JH; Busch OR; van Berge Henegouwen MI
    Ann Surg Oncol; 2012 Mar; 19(3):766-71. PubMed ID: 21979112
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of Preoperative Skeletal Muscle Mass and Nutritional Status on Short-and Long-Term Outcomes After Esophagectomy for Esophageal Cancer: A Retrospective Observational Study : Impact of Psoas Muscle Mass and Body Mass on Esophagectomy.
    Shichinohe T; Uemura S; Hirano S; Hosokawa M
    Ann Surg Oncol; 2019 May; 26(5):1301-1310. PubMed ID: 30725311
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictive Value of Body Mass Index for Short-Term Outcomes of Patients with Esophageal Cancer After Esophagectomy: A Meta-analysis.
    Wang P; Li Y; Sun H; Liu S; Zhang R; Liu X; Zhu Z
    Ann Surg Oncol; 2019 Jul; 26(7):2090-2103. PubMed ID: 30937663
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic significance of body mass indices for patients undergoing esophagectomy for cancer.
    Morgan MA; Lewis WG; Hopper AN; Escofet X; Harvard TJ; Brewster AE; Crosby TD; Roberts SA; Clark GW
    Dis Esophagus; 2007; 20(1):29-35. PubMed ID: 17227307
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of human epidermal growth factor receptor 2 as a prognostic factor for survival in esophageal carcinoma: evidence from 2872 subjects.
    Wang WJ; Wu MJ; Chang J; Xie P; Lu ZQ; Ren JL
    Minerva Med; 2016 Oct; 107(5):328-41. PubMed ID: 27309036
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic significance of the pN classification supplemented by body mass index for esophageal squamous cell carcinoma.
    Wang F; Duan H; Cai M; Fu J; Ma G; Yang H; Tan Z; Hu R; Lin P; Zhang X
    Thorac Cancer; 2015 Nov; 6(6):765-71. PubMed ID: 26557916
    [TBL] [Abstract][Full Text] [Related]  

  • 28. C-Met as a potential novel prognostic marker in squamous cell carcinoma and adenocarcinoma of esophagus: evidence from a meta-analysis.
    Ren JL; Wu HF; Wang WJ; Hu GM; Gu B; Zhang M; Wang YX
    Panminerva Med; 2017 Mar; 59(1):97-106. PubMed ID: 27636117
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic Impact of Postoperative Morbidity After Esophagectomy for Esophageal Cancer: Exploratory Analysis of JCOG9907.
    Kataoka K; Takeuchi H; Mizusawa J; Igaki H; Ozawa S; Abe T; Nakamura K; Kato K; Ando N; Kitagawa Y
    Ann Surg; 2017 Jun; 265(6):1152-1157. PubMed ID: 27280509
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of miR-21 and miR-375 as prognostic biomarkers in esophageal cancer.
    Winther M; Alsner J; Tramm T; Baeksgaard L; Holtved E; Nordsmark M
    Acta Oncol; 2015; 54(9):1582-91. PubMed ID: 26481465
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Postoperative Radiotherapy Improves Survival in Stage pT2N0M0 Esophageal Squamous Cell Carcinoma with High Risk of Poor Prognosis.
    Wang S; Wang Z; Yang Z; Liu Y; Liu X; Shang B; Jiang WP
    Ann Surg Oncol; 2016 Jan; 23(1):265-72. PubMed ID: 26014154
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early adulthood body mass index, cumulative smoking, and esophageal adenocarcinoma survival.
    Spreafico A; Coate L; Zhai R; Xu W; Chen ZF; Chen Z; Patel D; Tse B; Brown MC; Heist RS; Dodbiba L; Teichman J; Kulke M; Su L; Eng L; Knox J; Wong R; Darling GE; Christiani DC; Liu G
    Cancer Epidemiol; 2017 Apr; 47():28-34. PubMed ID: 28088657
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognosis and Treatment After Diagnosis of Recurrent Esophageal Carcinoma Following Esophagectomy with Curative Intent.
    Parry K; Visser E; van Rossum PS; Mohammad NH; Ruurda JP; van Hillegersberg R
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1292-300. PubMed ID: 26334295
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functional polymorphisms associated with disease-free survival in resected carcinoma of the esophagus.
    Boonstra JJ; van Marion R; Tilanus HW; Dinjens WN
    J Gastrointest Surg; 2011 Jan; 15(1):48-56. PubMed ID: 20922573
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [High BMI does not influence short- and long-term outcomes of patients with esophageal cancer treated with esophagectomy].
    Takemoto K; Shiozaki A; Fujiwara H; Konishi H; Morimura R; Murayama Y; Komatsu S; Kuriu Y; Ikoma H; Kubota T; Nakanishi M; Ichikawa D; Okamoto K; Sakakura C; Otsuji E
    Gan To Kagaku Ryoho; 2014 Nov; 41(12):1991-3. PubMed ID: 25731399
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neoadjuvant treatment response in negative nodes is an important prognosticator after esophagectomy.
    Nieman DR; Peyre CG; Watson TJ; Cao W; Lunt MD; Lada MJ; Han MS; Jones CE; Peters JH
    Ann Thorac Surg; 2015 Jan; 99(1):277-83. PubMed ID: 25442991
    [TBL] [Abstract][Full Text] [Related]  

  • 37. STMN-1 gene: a predictor of survival in stage iia esophageal squamous cell carcinoma after Ivor-Lewis esophagectomy?
    Akhtar J; Wang Z; Yu C; Zhang ZP; Bi MM
    Ann Surg Oncol; 2014 Jan; 21(1):315-21. PubMed ID: 23975322
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Validation of a new approach for mortality risk assessment in oesophagectomy for cancer based on age- and gender-corrected body mass index.
    Van Veer H; Moons J; Darling G; Lerut T; Coosemans W; Waddell T; De Leyn P; Nafteux P
    Eur J Cardiothorac Surg; 2015 Oct; 48(4):600-7. PubMed ID: 25564215
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endoscopic tumor length is an independent prognostic factor in esophageal squamous cell carcinoma.
    Wang BY; Liu CY; Lin CH; Hsu PK; Hsu WH; Wu YC; Cheng CY
    Ann Surg Oncol; 2012 Jul; 19(7):2149-58. PubMed ID: 22407313
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictive Factors of Recurrence in Patients with Pathological Complete Response After Esophagectomy Following Neoadjuvant Chemoradiotherapy for Esophageal Cancer: A Multicenter Study.
    Luc G; Gronnier C; Lebreton G; Brigand C; Mabrut JY; Bail JP; Meunier B; Collet D; Mariette C
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1357-64. PubMed ID: 26014152
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.